Genetics and Cytology Department, Biotechnology Research Institute, National Research Centre, Dokki, 12622, Giza, Egypt.
Cell Biology Department, Biotechnology Research Institute, National Research Centre, Dokki, 12622, Giza, Egypt.
Biol Trace Elem Res. 2023 Jan;201(1):353-367. doi: 10.1007/s12011-022-03154-1. Epub 2022 Feb 21.
Selenium-enriched Lactobacillus plantarum and Bifidobacterium longum mutants were used as a protector against Piroxicam-induced ulcerative colitis (UC). In this study, 32 BALB/c male mice were distributed to four groups: the control group, the Piroxicam group which was given 0.8 mg Piroxicam, SP and SB groups which were given 0.8 mg Piroxicam, and plus Lactobacillus plantarum and Bifidobacterium longum selenium-enriched mutants, respectively. Bodyweight; serum content of IgG, IgM, TNF-α, IL-2, IL-6, and IL-10; CBC; myeloperoxidase enzyme activity; histopathological examination of colon and spleen; and expression of TNF-α, IL-2, IL-6, and IL-10 genes in colon and spleen with qRT-PCR were determined. Bodyweight was found to reduce in the Piroxicam group and then recovery in the SB group. Serum content of IgG, IL-2, and IL-10 reduced in the Piroxicam group, whereas IgG, TNF-α, and IL-6 increased in the Piroxicam group in comparison to the other groups. Myeloperoxidase activity witnessed a significant increase in the Piroxicam group compared with the other groups. No significant differences were observed between all groups in measurements of red cells, hemoglobin, neutrophil, monocyte, eosinophil, and basophil in blood. Meanwhile, the white blood cells and platelets recorded the highest and lowest value, respectively, in the Piroxicam group. The colon of the Piroxicam group showed a noticeably massive infiltration of inflammatory cells in the lamina propria. These inflammations were mildly reduced in the SP group, while the reduction in the SB group was significant. In the Piroxicam group, splenic parenchyma saw an increase in the number of melanomacrophages, while hypertrophic plasma cells were observed in the SP group. The spleen of the SB group exhibits a nearly normal form. TNF-α and IL-6 genes had significantly upregulated in the colon of the Piroxicam group compared to the control group, while they were significantly downregulated in the SB group. In contrast, IL-2 and IL-10 genes had upregulated in the colon of the SB group compared to the control groups, while they had downregulated in the Piroxicam group. The expression of these genes had not recorded significant differences between all groups in the spleen. Therefore, this study recommends Bifidobacterium longum selenium-enriched mutants as anti-inflammatory and immunomodulatory supplements.
富硒植物乳杆菌和长双歧杆菌突变体被用作吡罗昔康诱导的溃疡性结肠炎(UC)的保护剂。在这项研究中,32 只雄性 BALB/c 小鼠被分为四组:对照组、给予 0.8mg 吡罗昔康的吡罗昔康组、给予 0.8mg 吡罗昔康和富硒植物乳杆菌和长双歧杆菌突变体的 SP 组和 SB 组。测定体重;血清 IgG、IgM、TNF-α、IL-2、IL-6 和 IL-10 含量;CBC;髓过氧化物酶酶活性;结肠和脾脏的组织病理学检查;以及用 qRT-PCR 检测结肠和脾脏中 TNF-α、IL-2、IL-6 和 IL-10 基因的表达。结果发现,吡罗昔康组体重减轻,随后 SB 组体重恢复。与其他组相比,吡罗昔康组血清 IgG、IL-2 和 IL-10 含量降低,而 IgG、TNF-α 和 IL-6 含量升高。与其他组相比,吡罗昔康组髓过氧化物酶活性显著升高。各组间血液中红细胞、血红蛋白、中性粒细胞、单核细胞、嗜酸性粒细胞和嗜碱性粒细胞无明显差异。同时,吡罗昔康组白细胞和血小板分别记录到最高和最低值。吡罗昔康组结肠固有层可见大量炎症细胞浸润。SP 组炎症减轻,而 SB 组炎症明显减轻。吡罗昔康组脾实质中黑素吞噬细胞数量增加,SP 组可见肥大浆细胞。SB 组脾脏呈近乎正常形态。与对照组相比,吡罗昔康组结肠中 TNF-α 和 IL-6 基因显著上调,而 SB 组显著下调。相反,与对照组相比,SB 组结肠中 IL-2 和 IL-10 基因上调,而吡罗昔康组下调。这些基因在脾中的表达在各组之间没有显著差异。因此,本研究推荐长双歧杆菌富硒突变体作为抗炎和免疫调节补充剂。